138 related articles for article (PubMed ID: 37742026)
1. Kynureninase knockdown inhibits cisplatin resistance in vivo and in vitro and impacts the prognosis of cervical adenocarcinoma.
Zhang JW; Wang YN; Zhong ML; Liang MR
Cell Div; 2023 Sep; 18(1):15. PubMed ID: 37742026
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of P16 reversed the MDR1-mediated DDP resistance in the cervical adenocarcinoma by activating the ERK1/2 signaling pathway.
Xiao Y; Liang MR; Liu CC; Wang YN; Zeng Y; Zhou J; Zhu HT; Wang Q; Zou Y; Zeng SY
Cell Div; 2019; 14():6. PubMed ID: 31312250
[TBL] [Abstract][Full Text] [Related]
3. SPP1 inhibition improves the cisplatin chemo-sensitivity of cervical cancer cell lines.
Chen X; Xiong D; Ye L; Yang H; Mei S; Wu J; Chen S; Mi R
Cancer Chemother Pharmacol; 2019 Apr; 83(4):603-613. PubMed ID: 30627777
[TBL] [Abstract][Full Text] [Related]
4. The Effects Of Sevoflurane On The Progression And Cisplatinum Sensitivity Of Cervical Cancer Cells.
Xue F; Xu Y; Song Y; Zhang W; Li R; Zhu X
Drug Des Devel Ther; 2019; 13():3919-3928. PubMed ID: 31819366
[TBL] [Abstract][Full Text] [Related]
5. TMEM45A Affects Proliferation, Apoptosis, Epithelial-Mesenchymal Transition, Migration, Invasion and Cisplatin Resistance of HPV-Positive Cervical Cancer Cell Lines.
Liu Y; Liu L; Mou ZX
Biochem Genet; 2022 Feb; 60(1):173-190. PubMed ID: 34143331
[TBL] [Abstract][Full Text] [Related]
6. circ-LDLRAD3 Knockdown Reduces Cisplatin Chemoresistance and Inhibits the Development of Gastric Cancer with Cisplatin Resistance through miR-588 Enrichment-Mediated SOX5 Inhibition.
Liang Q; Chu F; Zhang L; Jiang Y; Li L; Wu H
Gut Liver; 2023 May; 17(3):389-403. PubMed ID: 35975639
[TBL] [Abstract][Full Text] [Related]
7. Interference with endogenous EZH2 reverses the chemotherapy drug resistance in cervical cancer cells partly by up-regulating Dicer expression.
Cai L; Wang Z; Liu D
Tumour Biol; 2016 May; 37(5):6359-69. PubMed ID: 26631032
[TBL] [Abstract][Full Text] [Related]
8. The role of emodin on cisplatin resistance reversal of lung adenocarcinoma A549/DDP cell.
Teng X; Wang SY; Shi YQ; Fan XF; Liu S; Xing Y; Guo YY; Dong M
Anticancer Drugs; 2021 Oct; 32(9):939-949. PubMed ID: 34001704
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA hsa_circ_0096157 contributes to cisplatin resistance by proliferation, cell cycle progression, and suppressing apoptosis of non-small-cell lung carcinoma cells.
Lu H; Xie X; Wang K; Chen Q; Cai S; Liu D; Luo J; Kong J
Mol Cell Biochem; 2020 Dec; 475(1-2):63-77. PubMed ID: 32767026
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of circ‑PVT1 inhibits the progression of lung adenocarcinoma and enhances the sensitivity to cisplatin via the miR‑429/FOXK1 signaling axis.
Cao L; Zhou X; Ding X; Gao D
Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34328193
[TBL] [Abstract][Full Text] [Related]
11. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
Shi H; Pu J; Zhou XL; Ning YY; Bai C
Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
[TBL] [Abstract][Full Text] [Related]
12. [Inhibiting HSP70 expression enhances cisplatin sensitivity of cervical cancer cells].
Liu J; Liu J; Li SZ; Zheng YA; Guo SY; Wang X
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 37(4):475-481. PubMed ID: 28446399
[TBL] [Abstract][Full Text] [Related]
13. LncRNA NNT-AS1 contributes to the cisplatin resistance of cervical cancer through NNT-AS1/miR-186/HMGB1 axis.
Liu Y; Guo R; Qiao Y; Han L; Liu M
Cancer Cell Int; 2020; 20():190. PubMed ID: 32489326
[TBL] [Abstract][Full Text] [Related]
14. [Effect of RBP2 gene silencing on proliferation, migration and invasion of ovarian epithelial cancer SKOV3/DDP cells and its mechanism].
Feng TF; Yao DM; Zheng R; Jiang DS; Zhang LL; Xing Q; Li L
Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):139-146. PubMed ID: 35184457
[No Abstract] [Full Text] [Related]
15. Celastrol Inhibits the Proliferation and Decreases Drug Resistance of Cisplatin- Resistant Gastric Cancer SGC7901/DDP Cells.
Zhan D; Ni T; Wang H; Lv M; Sunagawa M; Liu Y
Anticancer Agents Med Chem; 2022; 22(2):270-279. PubMed ID: 34053427
[TBL] [Abstract][Full Text] [Related]
16. Depleted aldehyde dehydrogenase 1A1 (ALDH1A1) reverses cisplatin resistance of human lung adenocarcinoma cell A549/DDP.
Wei Y; Wu S; Xu W; Liang Y; Li Y; Zhao W; Wu J
Thorac Cancer; 2017 Jan; 8(1):26-32. PubMed ID: 27813328
[TBL] [Abstract][Full Text] [Related]
17. [The roles of holothurian glycosaminoglycan combined with cisplatin on proliferation and chemotherapeutic response in A549 human lung adenocarcinoma cell].
Jin Q; Zhu XH; Lin CZ; Zhang H; Cao YW; Ding XQ; Lyu ZH
Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):252-257. PubMed ID: 29730910
[No Abstract] [Full Text] [Related]
18. Design and Synthesis of Novel α-Methylchalcone Derivatives, Anti-Cervical Cancer Activity, and Reversal of Drug Resistance in HeLa/DDP Cells.
Yang Z; Liu Z; Ablise M; Maimaiti A; Aihaiti A; Alimujiang Y
Molecules; 2023 Nov; 28(23):. PubMed ID: 38067428
[TBL] [Abstract][Full Text] [Related]
19. Reversal of galectin-1 gene silencing on resistance to cisplatin in human lung adenocarcinoma A549 cells.
Zhang L; Liu X; Tang Z; Li X; Wang G
Biomed Pharmacother; 2016 Oct; 83():265-270. PubMed ID: 27392028
[TBL] [Abstract][Full Text] [Related]
20. XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells.
Teng X; Fan XF; Li Q; Liu S; Wu DY; Wang SY; Shi Y; Dong M
Oncol Rep; 2019 Mar; 41(3):1875-1882. PubMed ID: 30628719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]